Latest Comorbidity Stories
Researchers from Rhode Island Hospital's department of psychiatry propose that the definition for major depressive disorder (MDD) should be shortened to include only the mood and cognitive symptoms that have been part of the definition in the Diagnostic and Statistical Manual of Mental Disorders (DSM) for the past 35 years.
NEW HAVEN, Conn., May 29 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC.
Rich Data Set and Easy-to-Use Web Interface Allows Users to Manipulate Data to Create Custom Epidemiological Projections PatientBase Also Offers Treatable Pools for Its Cancer Indications WALTHAM, Mass., May 7 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, announces the completion of PatientBase's forecast period and disease indication updates.
New Study Published in the Journal of Rheumatology Examines Quality of Life and Disability in Treatment Failure Gout Patients EAST BRUNSWICK, N.J., May 5 /PRNewswire-FirstCall/ -- Savient Pharmaceuticals, Inc.
JAMA commentary highlights startling lack of focus on costly problem NASHVILLE, Tenn., April 8 /PRNewswire/ -- MedSolutions (www.medsolutions.com), a provider of medical cost management services that help health plans control diagnostic imaging costs while improving quality of care, today commended a recent Journal of the American Medical Association (JAMA) commentary that calls for the medical community to address the growing issue of diagnostic errors. In their report ("Diagnostic Errors...
A new study may help doctors determine who is a good candidate for an implanted defibrillator -- and who is not.
A U.S. study suggests older people with comorbidities or multiple hospital admissions for heart failure receive little benefit from implanted defibrillators. The cohort study was conducted among more than 14,000 patients with heart failure using an administrative five-year data base.
American Heart Association rapid access journal report: Study highlights: -- Implantable cardioverter defibrillators (ICDs) may reduce the risk of death by 30 percent in patients with reduced heart function. -- This survival benefit applied to patients 75 years and older in this primary prevention study. -- Previous studies have focused on younger, healthier patients. DALLAS, Jan.
Implantable cardioverter defibrillators (ICDs) can improve survival in patients with heart damage "” even those in their 70s "” according to research reported in Circulation: Cardiovascular Quality and Outcomes.Implanted ICDs reduced the risk of dying by 30 percent in patients younger than 65 years old, 65 to 74, and 75 and older, said Paul Chan, M.D., M.Sc., lead author of the study and assistant professor at the Mid-America Heart Institute and the University of Missouri in...
By Smith, Ashley Wilder Reeve, Bryce B; Bellizzi, Keith M; Harlan, Linda C; Klabunde, Carrie N; Amsellem, Marni; Bierman, Arlene S; Hays, Ron D This study examined the physical and mental health of 126,685 males and females age 65 or over, with and without cancer that completed a Medicare Health Outcomes Survey (MHOS) between 1998- 2002.